Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients

Balandin, B; Ballesteros, D; de Luna, RR; Lopez-Vergara, L; Pintado, V; Sancho-Gonzalez, M; Soriano-Cuesta, C; Perez-Pedrero, MJ; Asensio-Martin, MJ; Fernandez-Simon, I; Rodriguez-Serrano, D; Silva, A; Chicot, M; Iranzo, R; Martinez-Sagasti, F; Royuela, A

Balandin, B (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Dept Crit Care Med, C Manuel de Falla 1, Madrid 28222, Spain.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021; 57 (3):

Abstract

Background: This study aimed to assess the efficacy of ceftolozane-tazobactam (C/T) for treating infections due to Pseudomonas aeruginosa ( P. aerugin......

Full Text Link